Characteristics of L-citrulline transport through blood-brain barrier in the brain capillary endothelial cell line (TR-BBB cells)

被引:16
作者
Lee, Kyeong-Eun
Kang, Young-Sook [1 ]
机构
[1] Sookmyung Womens Univ, Coll Pharm, 52 Hyochangwon Gil, Seoul 140742, South Korea
基金
新加坡国家研究基金会;
关键词
L-Citrulline; Blood-brain barrier (BBB); Large amino acid transporter 1(LAT1); Nitric oxide ( NO); L-Dopa-Gabapentin; AMINO-ACID TRANSPORTER; NITRIC-OXIDE SYNTHESIS; RAT-BRAIN; THERAPEUTIC-USE; L-DOPA; ARGININE; MODEL; DISEASE; PLASMA; METABOLISM;
D O I
10.1186/s12929-017-0336-x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Background: L-Citrulline is a neutral amino acid and a major precursor of L-arginine in the nitric oxide (NO) cycle. Recently it has been reported that L-citrulline prevents neuronal cell death and protects cerebrovascular injury, therefore, L-citrulline may have a neuroprotective effect to improve cerebrovascular dysfunction. Therefore, we aimed to clarify the brain transport mechanism of L-citrulline through blood-brain barrier (BBB) using the conditionally immortalized rat brain capillary endothelial cell line (TR-BBB cells), as an in vitro model of the BBB. Methods: The uptake study of [C-14] L-citrulline, quantitative real-time polymerase chain reaction (PCR) analysis, and rLAT1, system b(0,+), and CAT1 small interfering RNA study were performed in TR-BBB cells. Results: The uptake of [C-14] L-citrulline was a time-dependent, but ion-independent manner in TR-BBB cells. The transport process involved two saturable components with a Michaelis-Menten constant of 30.9 +/- 1.0 mu M (Km(1)) and 1.69 +/- 0.43 mM (Km(2)). The uptake of [C-14] L-citrulline in TR-BBB cells was significantly inhibited by neutral and cationic amino acids, but not by anionic amino acids. In addition, [C-14] L-citrulline uptake in the cells was markedly inhibited by 2-aminobicyclo-(2,2,1)-heptane-2-carboxylic acid (BCH), which is the inhibitor of the large neutral amino acid transporter 1 (LAT1), B-0, B-0,B-+ and harmaline, the inhibitor of system b(0,+). Gabapentin and L-dopa as the substrates of LAT1 competitively inhibited the uptake of [14C] L-citrulline. IC50 values for L-dopa, gabapentin, L-phenylalanine and L-arginine were 501 mu M, 223 mu M, 68.9 mu M and 33.4 mM, respectively. The expression of mRNA for LAT1 was predominantly increased 187-fold in comparison with that of system b(0,+) in TR-BBB cells. In the studies of LAT1, system b(0,+) and CAT1 knockdown via siRNA transfection into TR-BBB cells, the transcript level of LAT1 and [C-14] L-citrulline uptake by LAT1 siRNA were significantly reduced compared with those by control siRNA in TR- BBB cells. Conclusions: Our results suggest that transport of L-citrulline is mainly mediated by LAT1 in TR-BBB cells. Delivery strategy for LAT1-mediated transport and supply of L-citrulline to the brain may serve as therapeutic approaches to improve its neuroprotective effect in patients with cerebrovascular disease.
引用
收藏
页数:10
相关论文
共 50 条
[41]   Exploring Kp,uu,BBB values smaller than unity in remoxipride: A physiologically-based CNS model approach highlighting brain metabolism in drugs with passive blood-brain barrier transport [J].
Zhang, Mengxu ;
Vuist, Ilona M. ;
Rottschafer, Vivi ;
Lange, Elizabeth C. M. de .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2024, 203
[42]   Purine receptors and Ca2+ signalling in the human blood-brain barrier endothelial cell line hCMEC/D3 [J].
Bintig, Willem ;
Begandt, Daniela ;
Schlingmann, Barbara ;
Gerhard, Linda ;
Pangalos, Maria ;
Dreyer, Lutz ;
Hohnjec, Natalija ;
Couraud, Pierre-Olivier ;
Romero, Ignacio A. ;
Weksler, Babette B. ;
Ngezahayo, Anaclet .
PURINERGIC SIGNALLING, 2012, 8 (01) :71-80
[43]   Immuno-metabolic impact of the multiple sclerosis patients’ sera on endothelial cells of the blood-brain barrier [J].
M. H. Sheikh ;
S. M. Henson ;
R. A. Loiola ;
S. Mercurio ;
A. Colamatteo ;
G. T. Maniscalco ;
V. De Rosa ;
S. McArthur ;
E. Solito .
Journal of Neuroinflammation, 17
[44]   Tumor Necrosis Factor-α Mediates the Blood-Brain Barrier Dysfunction Induced by Activated Microglia in Mouse Brain Microvascular Endothelial Cells [J].
Nishioku, Tsuyoshi ;
Matsumoto, Junichi ;
Dohgu, Shinya ;
Sumi, Noriko ;
Miyao, Kenji ;
Takata, Fuyuko ;
Shuto, Hideki ;
Yamauchi, Atsushi ;
Kataoka, Yasufumi .
JOURNAL OF PHARMACOLOGICAL SCIENCES, 2010, 112 (02) :251-254
[45]   Development of a three-dimensional blood-brain barrier network with opening capillary structures for drug transport screening assays [J].
Piantino, Marie ;
Kang, Dong-Hee ;
Furihata, Tomomi ;
Nakatani, Noriyuki ;
Kitamura, Kimiko ;
Shigemoto-Mogami, Yukari ;
Sato, Kaoru ;
Matsusaki, Michiya .
MATERIALS TODAY BIO, 2022, 15
[46]   Inhibiting ferroptosis in brain microvascular endothelial cells: A potential strategy to mitigate polystyrene nanoplastics-induced blood-brain barrier dysfunction [J].
Li, Chao ;
Chen, Xiaoshu ;
Du, Zhongjun ;
Geng, Xiao ;
Li, Ming ;
Yang, Xiaohan ;
Bo, Cunxiang ;
Jia, Qiang ;
Yu, Gongchang ;
Shi, Liang .
ENVIRONMENTAL RESEARCH, 2024, 250
[47]   Rapid, Reversible Modulation of Blood-Brain Barrier P-Glycoprotein Transport Activity by Vascular Endothelial Growth Factor [J].
Hawkins, Brian T. ;
Sykes, Destiny B. ;
Miller, David S. .
JOURNAL OF NEUROSCIENCE, 2010, 30 (04) :1417-1425
[48]   The L-isomer-selective transport of aspartic acid is mediated by ASCT2 at the blood-brain barrier [J].
Tetsuka, K ;
Takanaga, H ;
Ohtsuki, S ;
Hosoya, K ;
Terasaki, T .
JOURNAL OF NEUROCHEMISTRY, 2003, 87 (04) :891-901
[49]   Interleukin-34 Restores Blood-Brain Barrier Integrity by Upregulating Tight Junction Proteins in Endothelial Cells [J].
Jin, Shijie ;
Sonobe, Yoshifumi ;
Kawanokuchi, Jun ;
Horiuchi, Hiroshi ;
Cheng, Yi ;
Wang, Yue ;
Mizuno, Tetsuya ;
Takeuchi, Hideyuki ;
Suzumura, Akio .
PLOS ONE, 2014, 9 (12)
[50]   Human pluripotent stem cell-derived brain pericyte-like cells induce blood-brain barrier properties [J].
Stebbins, Matthew J. ;
Gastfriend, Benjamin D. ;
Canfield, Scott G. ;
Lee, Ming-Song ;
Richards, Drew ;
Faubion, Madeline G. ;
Li, Wan-Ju ;
Daneman, Richard ;
Palecek, Sean P. ;
Shusta, Eric, V .
SCIENCE ADVANCES, 2019, 5 (03)